GLENNA SMITH: Open Payments
NPI 1659871309 · ASHLAND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 9 payments from 7 companies in 2025. Trend: 2023 $215 · 2024 $405 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: TRINTELLIX, VRAYLAR, INGREZZA, Jornay PM, REXULTI, COBENFY, CAPLYTA.
Industry payments across VA — which companies pay providers there.
